ArticleNature communications2019

CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors.

Linchun Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.